American Oncology Network, Inc.

American Oncology Network, Inc. (AON) is a physician-led oncology management services company headquartered in Fort Myers, Florida. Founded in 2018, AON's core mission is to ensure the long-term success and viability of community oncology practices, aiming to improve patient outcomes, reduce costs, and expand access to quality cancer care across the United States.

The company provides comprehensive oncology services and practice management solutions to its network of community-based oncology practices. Key offerings include drug procurement, payor contracting, centralized laboratory and pathology services, specialty pharmacy services (including home delivery of oral oncolytics), clinical research, radiation oncology, imaging, infusion therapy, care coordination, and access to innovative clinical trials.

AON became a publicly traded entity in September 2023 following a business combination with Digital Transformation Opportunities Corp. (DTOC), with its common stock trading on the Nasdaq Stock Market under the ticker symbol AONC. Led by CEO Todd Schonherz and Chief Medical Officer Dr. Stephen "Fred" Divers, AON has demonstrated significant growth, reporting annual revenue surpassing $2 billion and a provider network of over 300 across 20 states in 2025. Recent initiatives include expanding access to Bispecific T-cell Engager (BiTE) therapy in over 40 clinics and partnering to enhance cancer care with AI.